Regorafenib in Subjects With Metastatic Colorectal Cancer (mCRC) Who Have Progressed After Standard Therapy

Clinical trial NCT01853319 · COMPLETED

Trial details

NCT number: NCT01853319
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Colorectal Neoplasms

Start date: 2013-07-24
Primary completion: 2015-04-24
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.